
Luminare is a healthcare technology company focused on improving patient outcomes through its patented patient phenotyping algorithm, specifically targeting sepsis management. By integrating seamlessly with existing EHR systems, Luminare enhances clinical workflows, reduces nurse workload, and ultimately saves lives while generating revenue for healthcare organizations. The company has demonstrated significant traction, with clients reporting substantial reductions in mortality rates and ICU admissions. Luminare's comprehensive approach differentiates it from competitors by addressing the entire scope of sepsis detection and treatment, positioning it as a leader in the healthcare technology market.

Luminare is a healthcare technology company focused on improving patient outcomes through its patented patient phenotyping algorithm, specifically targeting sepsis management. By integrating seamlessly with existing EHR systems, Luminare enhances clinical workflows, reduces nurse workload, and ultimately saves lives while generating revenue for healthcare organizations. The company has demonstrated significant traction, with clients reporting substantial reductions in mortality rates and ICU admissions. Luminare's comprehensive approach differentiates it from competitors by addressing the entire scope of sepsis detection and treatment, positioning it as a leader in the healthcare technology market.
Focus: AI-driven sepsis detection and end-to-end sepsis care workflow improvement
Technology: Patented patient phenotyping algorithm; integrates with EHRs via HL7/FHIR
Reported impact: Clients cite reductions in mortality, ICU length of stay, and ventilator days
Employees: 39
Headquarters: Houston, TX
Sepsis detection and clinical workflow optimization in hospitals
2014
Healthcare technology
Total Funding: 7050000.00 USD